The news on Biogen
There has been 19 news on Biogen in the past from 11 different sources and amongst 2 sections.
Full access to all news in this scope:
See the trend on this scope:
Evolution through time
Latest news
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Sage Therapeutics Jumps on Biogen's $469 Million Takeover Offer
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Biogen is buying up an immune drug developer for $1.8 billion
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Biogen to stop selling controversial Alzheimer's drug Aduhelm
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Biogen Quits Controversial Alzheimer's Drug Aduhelm
Biogen Plans to Shut Down Its Controversial Alzheimer's Drug Aduhelm
Biogen scraps controversial Alzheimer's drug Aduhelm
Biogen to shut down its controversial Alzheimer's drug Aduhelm
Biogen to cease production of controversial Alzheimer's drug
Sections
The coverage spreads amongst 2 sections:
Sources
There has been 11 news sources reporting on this, including: CNBC News (42%), Quartz (11%), Politico (5%), Time (5%), CBS (5%).
Going further
Stay up to date:
Details
This content can be used under the CC BY 4.0 license